Results 301 to 310 of about 106,358 (395)
Refractory Dermatitis Evolving Into Lupus Spectrum Disease in the Setting of Dupilumab Use. [PDF]
CureusJoseph JM, Kilgore J, Culotta N.
europepmc +1 more source
Teaching Neuro Images : Hydroxychloroquine-induced vacuolar myopathy [PDF]
, 2013 Partha S. Ghosh +2 more
openalex +1 more source
Hyperpigmentation Induced by Hydroxychloroquine
Dermatology Practical & Conceptual, 2023 openaire +3 more sources
Hydroxychloroquine and pain thresholds [PDF]
Arthritis & Rheumatism, 1995 Gregg D. Middleton +2 more
openaire +3 more sources
Arthritis Care &Research, Volume 77, Issue 5, Page 604-613, May 2025.Objective Osteoporosis, a known complication of rheumatoid arthritis (RA), increases the risk of hip fracture, which is associated with high morbidity and mortality. Fracture risk estimates in patients with RA treated with contemporary treatment strategies are lacking.
C. Allyson Jones +5 more
wiley +1 more source
Evaluation of link between COVID-19 adjacent spike in hydroxychloroquine use and increased reports of pemphigus: a disproportionality analysis of the FDA Adverse Event Reporting System. [PDF]
Front ImmunolBaroukhian J +3 more
europepmc +1 more source
Role of STING Deficiency in Amelioration of Mouse Models of Lupus and Atherosclerosis
Arthritis &Rheumatology, Volume 77, Issue 5, Page 547-559, May 2025.Objective Systemic lupus erythematosus (SLE) is a systemic autoimmune syndrome characterized by autoreactive responses to nucleic acids, dysregulation of the type I interferon (IFN‐I) pathway, and accelerated atherosclerosis. The stimulator of IFN genes (STING), a cytosolic DNA sensor, has pathogenic implications in various inflammatory diseases ...
Yudong Liu +10 more
wiley +1 more source
Correction: Hydroxychloroquine in patients with systemic lupus erythematosus: how much is enough? [PDF]
Lupus Sci Medeuropepmc +1 more source